OCLG OTC
Oncologix Tech Inc.
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: -86.7%
5Y: -95.7%
$0.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.1M
52W Range0.00001-0.0001
Volume198,200
Avg Volume206,266
Beta0.00
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOMichael A. Kramarz
Employees191
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date1995-03-08
Websiteoclghealth.com
1604 West Pinhook Drive Suite 200
Lafayette, LA 70508
US
Lafayette, LA 70508
US
616-977-9933
About Oncologix Tech Inc.
Oncologix Tech, Inc. is a biopharmaceutical company whose main products include DNAGO and genomego which provides clinical genetic testing on all 20,000+ genes encompassing over 7,000 rare genetic diseases. It also previously operated in personal home care services and the manufacturing and distribution of medical technologies. The company was formerly known as BestNet Communications Corp. and changed its name to Oncologix Tech, Inc. in January 2007.
Latest News
No recent news
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| SILVERMAN ANTHONY | A-Award | 1,024,164 | $0.01 | 2013-02-08 |
| SILVERMAN ANTHONY | J-Other | 1,024,164 | $0.01 | 2013-02-08 |
| SILVERMAN ANTHONY | C-Conversion | 1,024,164 | $0.01 | 2013-02-08 |
| SILVERMAN ANTHONY | D-Return | 250,000 | $0.04 | 2012-01-26 |
| SILVERMAN ANTHONY | D-Return | 250,000 | $0.04 | 2012-01-26 |